These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 35862373)
1. VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types. Sarkar J; Luo Y; Zhou Q; Ivakhnitskaia E; Lara D; Katz E; Sun MG; Guaiquil V; Rosenblatt M PLoS One; 2022; 17(7):e0269818. PubMed ID: 35862373 [TBL] [Abstract][Full Text] [Related]
2. Heterodimerisation between VEGFR-1 and VEGFR-2 and not the homodimers of VEGFR-1 inhibit VEGFR-2 activity. Cai M; Wang K; Murdoch CE; Gu Y; Ahmed A Vascul Pharmacol; 2017 Jan; 88():11-20. PubMed ID: 27884759 [TBL] [Abstract][Full Text] [Related]
3. Trafficking dynamics of VEGFR1, VEGFR2, and NRP1 in human endothelial cells. Sarabipour S; Kinghorn K; Quigley KM; Kovacs-Kasa A; Annex BH; Bautch VL; Mac Gabhann F PLoS Comput Biol; 2024 Feb; 20(2):e1011798. PubMed ID: 38324585 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes. Tanaka K; Watanabe M; Tanigaki S; Iwashita M; Kobayashi Y Placenta; 2018 Dec; 74():20-27. PubMed ID: 30591201 [TBL] [Abstract][Full Text] [Related]
5. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490 [TBL] [Abstract][Full Text] [Related]
6. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells. Mac Gabhann F; Popel AS Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333 [TBL] [Abstract][Full Text] [Related]
12. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [TBL] [Abstract][Full Text] [Related]
13. A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands. Clegg LE; Mac Gabhann F PLoS Comput Biol; 2017 Mar; 13(3):e1005445. PubMed ID: 28319199 [TBL] [Abstract][Full Text] [Related]
14. Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo. Szabo E; Schneider H; Seystahl K; Rushing EJ; Herting F; Weidner KM; Weller M Neuro Oncol; 2016 Sep; 18(9):1242-52. PubMed ID: 27009237 [TBL] [Abstract][Full Text] [Related]
16. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway. Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659 [TBL] [Abstract][Full Text] [Related]
17. Fluorescent resonance energy transfer imaging of VEGFR dimerization. Ahmadova Z; Yagublu V; Förg T; Hajiyeva Y; Jesenofsky R; Hafner M; Keese M Anticancer Res; 2014 May; 34(5):2123-33. PubMed ID: 24778014 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303 [TBL] [Abstract][Full Text] [Related]
19. VEGF and his R1 and R2 receptors expression in mast cells of oral squamous cells carcinomas and their involvement in tumoral angiogenesis. Ciurea R; Mărgăritescu C; Simionescu C; Stepan A; Ciurea M Rom J Morphol Embryol; 2011; 52(4):1227-32. PubMed ID: 22203927 [TBL] [Abstract][Full Text] [Related]
20. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG; Kim TD; Li G; Yoon WH; Chae CB Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]